Bioregulator Immune / Thymic

Research Benefits

• Thymic Reconstitution: Extensively studied for reversing age-related thymic involution and restoring T-cell production capacity
• Immune Competence: Research demonstrates enhanced T-cell maturation, differentiation, and functional activity in aging immune system models
• Immunosenescence Reversal: Khavinson's landmark studies show potential for restoring naive T-cell populations and diversifying the T-cell receptor repertoire
• Cytokine Balance: Investigated for normalizing Th1/Th2 cytokine ratios, supporting balanced immune surveillance
• Natural Killer Cell Activity: Studies report enhanced NK cell cytotoxicity and innate immune function

Mechanism of Action

The thymic bioregulator is among the most extensively studied of the Khavinson peptide class. Its primary mechanism involves direct interaction with DNA in thymic epithelial cells, modulating the expression of genes essential for T-cell education and immune system maintenance.

Key Pathways

• Thymic Epithelial Regeneration: Promotes gene expression in thymic epithelial cells, potentially reversing age-related atrophy and fatty replacement of thymic tissue
• T-Cell Maturation: Enhances expression of thymic hormones (thymosin, thymopoietin) that guide T-cell differentiation from bone marrow precursors
• Telomerase Activation: Published research indicates potential for activating telomerase in immune cells, supporting lymphocyte longevity and replicative capacity
• Cytokine Gene Regulation: Modulates transcription of IL-2, IL-7, and other cytokines critical for T-cell homeostasis

Research Protocol

For research purposes only. Not for human consumption.

• Typical Research Dose: 10-20 mg per administration
• Administration: Subcutaneous injection in most published protocols
• Research Cycle: 10-day cycles reported in the majority of Khavinson's publications, often repeated at 3-6 month intervals
• Combination Protocols: Frequently studied alongside pineal and cardiovascular bioregulators in multi-system aging research

Reconstitution

• Reconstitute with bacteriostatic water
• Gently swirl; do not agitate
• Store reconstituted solution at 2-8 °C; use within 30 days

Safety & Storage

• Lyophilized: -20 °C for long-term stability; 2-8 °C up to 12 months
• Reconstituted: 2-8 °C; use within 30 days
• Protect from light; avoid freeze-thaw cycles

Research Considerations

• Thymic bioregulators have the longest safety record in Khavinson's published research, spanning over 30 years of study
• Not recommended for study in conjunction with immunosuppressive compounds, as opposing mechanisms may confound results
• Caution in autoimmune disease models where enhanced immune activity could be counterproductive
• For research use only

Frequently Asked Questions

• Why is the thymus important in aging research?

  The thymus is the primary organ for T-cell maturation, and it undergoes significant involution with age. By age 60, thymic tissue is largely replaced by fat, severely limiting the production of new naive T-cells. Thymic bioregulators are studied for their potential to reverse this process.

• What evidence supports thymic bioregulators?

  Khavinson's research group has published extensively on thymic peptides, including studies showing restored T-cell counts, improved immune markers, and enhanced thymic morphology in aging models. Some of the most cited bioregulator papers focus on thymic peptides.

• How does this compare to thymosin alpha-1?

  While thymosin alpha-1 is a naturally occurring thymic hormone with well-established immunomodulatory effects, Khavinson's thymic bioregulators are shorter synthetic peptides designed to modulate gene expression at the epigenetic level rather than acting as direct signaling molecules.

• What purity standard is used?

  ≥99% purity verified by HPLC and mass spectrometry. Certificate of Analysis available for every batch.